Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2O3S |
| Molecular Weight | 296.385 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2
InChI
InChIKey=RIGBPMDIGYBTBJ-UHFFFAOYSA-N
InChI=1S/C14H20N2O3S/c1-11-7-9-13(10-8-11)20(18,19)16-14(17)15-12-5-3-2-4-6-12/h7-10,12H,2-6H2,1H3,(H2,15,16,17)
| Molecular Formula | C14H20N2O3S |
| Molecular Weight | 296.385 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Glycyclamide (Tolcyclamide) isn a cyclohexyl-containing sulfonylurea compound with antihyperglycemic activity. Tolcyclamide is closely related to tolbutamide, with a cyclohexyl ring in place of the butyl group. It is much less potent than glipizide, being active at a daily dose of 1000 mg.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis of a high-purity chemical library reveals a potent inducer of oxidative stress. | 2010-06-14 |
|
| Synthesis, characterization and DNA-binding studies of 1-cyclohexyl-3-tosylurea and its Ni(II), and Cd(II) complexes. | 2008-11-15 |
|
| Synthesis, characterization, antioxidant activity, and DNA-binding studies of 1-cyclohexyl-3-tosylurea and its Nd(III), Eu(III) complexes. | 2008-04 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:54:12 GMT 2025
by
admin
on
Wed Apr 02 06:54:12 GMT 2025
|
| Record UNII |
C40N4EJY68
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C97936
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1317
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
664-95-9
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
C65809
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
100000084233
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
C005008
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
SUB07952MIG
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
C40N4EJY68
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
211-557-6
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL312394
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
142661
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
m10941
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | Merck Index | ||
|
1324
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
DTXSID5046273
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY | |||
|
12628
Created by
admin on Wed Apr 02 06:54:12 GMT 2025 , Edited by admin on Wed Apr 02 06:54:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |